Cargando…
A Double Mutation of the Ryanodine Receptor Type 1 Gene in a Malignant Hyperthermia Family with Multiminicore Myopathy
BACKGROUND AND PURPOSE: At least 100 Ryanodine receptor type 1 (RYR1) mutations associated with malignant hyperthermia (MH) and central core disease (CCD) have been identified, but 2 RYR1 mutations accompanying multiminicore myopathy in an MH and/or CCD family have been reported only rarely. METHODS...
Autores principales: | Jeong, Seul-Ki, Kim, Dong-Chan, Cho, Yong-Gon, Sunwoo, Il-Nam, Kim, Dal-Sik |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Korean Neurological Association
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686874/ https://www.ncbi.nlm.nih.gov/pubmed/19513315 http://dx.doi.org/10.3988/jcn.2008.4.3.123 |
Ejemplares similares
-
Gene Panel Sequencing Identifies a Novel RYR1 p.Ser2300Pro Variant as Candidate for Malignant Hyperthermia with Multi-Minicore Myopathy
por: Moon, Young Jae, et al.
Publicado: (2022) -
Preclinical model systems of ryanodine receptor 1-related myopathies and malignant hyperthermia: a comprehensive scoping review of works published 1990–2019
por: Lawal, Tokunbor A., et al.
Publicado: (2020) -
Malignant hyperthermia
por: Kim, Dong-Chan
Publicado: (2012) -
Effects of Remimazolam and Propofol on Ca(2+) Regulation by Ryanodine Receptor 1 with Malignant Hyperthermia Mutation
por: Watanabe, Tomoyuki, et al.
Publicado: (2021) -
Exome analysis identifies Brody myopathy in a family diagnosed with malignant hyperthermia susceptibility
por: Sambuughin, Nyamkhishig, et al.
Publicado: (2014)